Hematological Malignancies

PET+ group: BEACOPPesc vs. ABVD Overall Survival (OS)

BEACOPPesc+INRT ABVD+INRT

HR (95% CI) = 0.45 (0.19, 1.07); p=0.062 5 yr OS: 96% vs. 89%

Raemaekers et at; ICML 2015